Virios Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Virios Therapeutics generated cash of -$4,870,489, which is more than the previous year. Cash used in financing activities reached the amount of $1,156,443 last year. Net change in cash is therefore -$3,714,046.
Cash Flow
| 2018 | -1.19M | 0 | 1.15M |
|---|---|---|---|
| 2019 | -2.09M | 0 | 2.37M |
| 2020 | -3.89M | 0 | 33.38M |
| 2021 | -15.68M | 0 | -97.60K |
| 2022 | -11.46M | 0 | 4.49M |
| 2023 | -4.87M | 0 | 1.15M |
VIRI Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 7.03M | 14.00M | 29.79M | 309.38K | 30.02K | 75.51K |
Operating activities | ||||||
Net income | -5.29M | -12.24M | -15.96M | -10.34M | -2.47M | -2.11M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 0 | 0 | 0 | 53.98K | 0 | 0 |
Stock-based compensation expense | 619.97K | 582.65K | 322.88K | 7.42M | 0 | 0 |
| Deferred income tax benefit | 619.97K | 582.65K | 322.88K | 7.42M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -461.25K | 219.30K | 270.00K | 51.56K | -89.82K | 65.63K |
Cash generated by operating activities | -4.87M | -11.46M | -15.68M | -3.89M | -2.09M | -1.19M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 1.15M | 4.49M | -97.60K | 31.34M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -295.16K | -1.85M | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -1.93M | 2.43M | 0 |
Cash used in financing activities | 1.15M | 4.49M | -97.60K | 33.38M | 2.37M | 1.15M |
Net Change In Cash | -3.71M | -6.97M | -15.78M | 29.48M | 279.35K | -45.48K |
Cash at end of period | 3.31M | 7.03M | 14.00M | 29.79M | 309.38K | 30.02K |
| Data source | Data source | Data source | Data source |